BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12602272)

  • 1. [The incidence of human papilloma virus (HPV) DNA in patients with cervical carcinoma from Gdansk region].
    Liss J; Łukaszuk K; Gulczyński J; Zwaliński M; Woźniak I; Emerich J; Wójcikowski C
    Ginekol Pol; 2002 Sep; 73(9):740-4. PubMed ID: 12602272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV detection in cervical cancer patients in northern Poland.
    Dybikowska A; Licznerski P; Podhajska A
    Oncol Rep; 2002; 9(4):871-4. PubMed ID: 12066224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human Papilloma virus in Quechua women from Jujuy with high frequency of cervical cancer: viral types and HPV-16 variants].
    Picconi MA; Gronda J; Alonio LV; Villa LL; Sichero L; Miranda S; Barcena M; Teyssie A
    Medicina (B Aires); 2002; 62(3):209-20. PubMed ID: 12150002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimation of HPV infection presence in cytological smears in a group of asymptomatic women].
    Łukaszuk K; Liss J; Zalewski J; Roter M; Brzóska B; Debniak J
    Wiad Lek; 2001; 54(9-10):508-15. PubMed ID: 11816294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women.
    Hwang T
    J Korean Med Sci; 1999 Dec; 14(6):593-9. PubMed ID: 10642935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of PCR technique in the evaluation of the frequency of HPV infection in vulvar and cervical carcinoma].
    Liss J; Emerich J; Lukaszuk K; Zwaliński M; Wójcikowski C
    Ginekol Pol; 1998 May; 69(5):330-4. PubMed ID: 9695337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
    Harnish DG; Belland LM; Scheid EE; Rohan TE
    Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of detection of human papillomavirus 16 DNA in cervical carcinoma tissues by Southern blot hybridisation and nested polymerase chain reaction.
    Chang DY; Hsieh CY; Chen RJ; Lee SC; Huang SC
    J Med Microbiol; 1995 Dec; 43(6):430-5. PubMed ID: 7473676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR.
    Clavel C; Rihet S; Masure M; Chypre C; Boulanger JC; Quereux C; Birembaut P
    J Clin Pathol; 1998 Jan; 51(1):38-43. PubMed ID: 9577370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
    Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
    Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
    Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of HPV infection of the uterine cervix among perimenopausal women in Wielkopolska Region].
    Zietkowiak W; Zimna K; Sroka Ł; Uchman P; Sajdak S
    Ginekol Pol; 2002 Nov; 73(11):939-44. PubMed ID: 12722378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients.
    Liu VW; Tsang P; Yip A; Ng TY; Wong LC; Ngan HY
    Gynecol Oncol; 2001 Aug; 82(2):269-72. PubMed ID: 11531278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus and human cytomegalovirus DNAs presence in patients suspected of condylomatosis or papillomatosis.
    Anton G; Achim R; Pleşa A; Repanovici R
    Rom J Virol; 1998; 49(1-4):83-8. PubMed ID: 10892429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are women with lupus at higher risk of HPV infection?
    Klumb EM; Pinto AC; Jesus GR; Araujo M; Jascone L; Gayer CR; Ribeiro FM; Albuquerque EM; Macedo JM
    Lupus; 2010 Nov; 19(13):1485-91. PubMed ID: 20605875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
    Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
    Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.